-
Je něco špatně v tomto záznamu ?
Detecting neuropsychiatric fluctuations in Parkinson's Disease using patients' own words: the potential of large language models
M. Castelli, M. Sousa, I. Vojtech, M. Single, D. Amstutz, ME. Maradan-Gachet, AD. Magalhães, I. Debove, J. Rusz, P. Martinez-Martin, R. Sznitman, P. Krack, T. Nef
Status neindexováno Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
40B2-0_194794
SNSF Bridge Discovery
40B2-0_194794
SNSF Bridge Discovery
32003BL_197709
SNF Lead Agency
NLK
Directory of Open Access Journals
od 2015
PubMed Central
od 2015
Europe PubMed Central
od 2015
ProQuest Central
od 2025-01-01
Open Access Digital Library
od 2015-04-22
Open Access Digital Library
od 2015-01-01
Health & Medicine (ProQuest)
od 2025-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2015
Springer Nature OA/Free Journals
od 2015-12-01
Springer Nature - nature.com Journals - Fully Open Access
od 2015-12-01
- Publikační typ
- časopisecké články MeSH
Over the past decade, neuropsychiatric fluctuations in Parkinson's disease (PD) have been increasingly recognized for their impact on patients' quality of life. Speech, a complex function carrying motor, emotional, and cognitive information, offers potential insights into these fluctuations. While previous studies have focused on acoustic analysis to assess motor speech disorders reliably, the potential of linguistic patterns associated with neuropsychiatric fluctuations in PD remains unexplored. This study analyzed the content of spontaneous speech from 33 PD patients in ON and OFF medication states, using machine learning and large language models (LLMs) to predict medication states and a neuropsychiatric state score. The top-performing model, the LLM Gemma-2 (9B), achieved 98% accuracy in differentiating ON and OFF states and its predicted scores were highly correlated with actual scores (Spearman's ρ = 0.81). These methods could provide a more comprehensive assessment of PD treatment effects, allowing remote neuropsychiatric symptom monitoring via mobile devices.
ARTORG Center for Biomedical Engineering Research AIMI University of Bern Bern Switzerland
Department of Neurology Bern University Hospital and University of Bern Bern Switzerland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25014523
- 003
- CZ-PrNML
- 005
- 20250905141446.0
- 007
- ta
- 008
- 250701s2025 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41531-025-00939-8 $2 doi
- 035 __
- $a (PubMed)40251156
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Castelli, Matilde $u ARTORG Center for Biomedical Engineering Research, Gerontechnology and Rehabilitation Group, University of Bern, Bern, Switzerland. matilde.castelli@unibe.ch
- 245 10
- $a Detecting neuropsychiatric fluctuations in Parkinson's Disease using patients' own words: the potential of large language models / $c M. Castelli, M. Sousa, I. Vojtech, M. Single, D. Amstutz, ME. Maradan-Gachet, AD. Magalhães, I. Debove, J. Rusz, P. Martinez-Martin, R. Sznitman, P. Krack, T. Nef
- 520 9_
- $a Over the past decade, neuropsychiatric fluctuations in Parkinson's disease (PD) have been increasingly recognized for their impact on patients' quality of life. Speech, a complex function carrying motor, emotional, and cognitive information, offers potential insights into these fluctuations. While previous studies have focused on acoustic analysis to assess motor speech disorders reliably, the potential of linguistic patterns associated with neuropsychiatric fluctuations in PD remains unexplored. This study analyzed the content of spontaneous speech from 33 PD patients in ON and OFF medication states, using machine learning and large language models (LLMs) to predict medication states and a neuropsychiatric state score. The top-performing model, the LLM Gemma-2 (9B), achieved 98% accuracy in differentiating ON and OFF states and its predicted scores were highly correlated with actual scores (Spearman's ρ = 0.81). These methods could provide a more comprehensive assessment of PD treatment effects, allowing remote neuropsychiatric symptom monitoring via mobile devices.
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Sousa, Mario $u Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland
- 700 1_
- $a Vojtech, Illner $u Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic
- 700 1_
- $a Single, Michael $u ARTORG Center for Biomedical Engineering Research, Gerontechnology and Rehabilitation Group, University of Bern, Bern, Switzerland
- 700 1_
- $a Amstutz, Deborah $u Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland
- 700 1_
- $a Maradan-Gachet, Marie Elise $u Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland
- 700 1_
- $a Magalhães, Andreia D $u Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland
- 700 1_
- $a Debove, Ines $u Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland
- 700 1_
- $a Rusz, Jan $u Department of Circuit Theory, Faculty of Electrical Engineering, Czech Technical University in Prague, Prague, Czech Republic
- 700 1_
- $a Martinez-Martin, Pablo $u Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Institute of Health, Madrid, Spain
- 700 1_
- $a Sznitman, Raphael $u ARTORG Center for Biomedical Engineering Research, AIMI, University of Bern, Bern, Switzerland
- 700 1_
- $a Krack, Paul $u Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland
- 700 1_
- $a Nef, Tobias $u ARTORG Center for Biomedical Engineering Research, Gerontechnology and Rehabilitation Group, University of Bern, Bern, Switzerland $u Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland
- 773 0_
- $w MED00208625 $t NPJ Parkinson's disease $x 2373-8057 $g Roč. 11, č. 1 (2025), s. 79
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40251156 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250701 $b ABA008
- 991 __
- $a 20250905141434 $b ABA008
- 999 __
- $a ok $b bmc $g 2388110 $s 1251643
- BAS __
- $a 3
- BAS __
- $a PreBMC-PubMed-not-MEDLINE
- BMC __
- $a 2025 $b 11 $c 1 $d 79 $e 20250418 $i 2373-8057 $m NPJ Parkinson's disease $n NPJ Parkinsons Dis $x MED00208625
- GRA __
- $a 40B2-0_194794 $p SNSF Bridge Discovery
- GRA __
- $a 40B2-0_194794 $p SNSF Bridge Discovery
- GRA __
- $a 32003BL_197709 $p SNF Lead Agency
- LZP __
- $a Pubmed-20250701